We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

260 hedge funds and large institutions have $6.22B invested in Alnylam Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 75

18% more capital invested

Capital invested by funds: $5.26B → $6.22B (+$960M)

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

1% more funds holding

Funds holding: 257 → 260 (+3)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

17% less call options, than puts

Call options by funds: $21M | Put options by funds: $25.4M

Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
6.82%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.18%
New
44
Increased
98
Reduced
75
Closed
39
Calls
$21M
Puts
$25.4M
Net Calls
-$4.4M
Net Calls Change
-$20.5M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$187M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$38.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.9M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$14.7M
5
SPC
Slate Path Capital
New York
+$12.1M

Top Sellers

1
AAMU
Amundi Asset Management US
Massachusetts
-$50.8M
2
First Trust Advisors
First Trust Advisors
Illinois
-$31.4M
3
UIM
USS Investment Management
United Kingdom
-$22.2M
4
CCM
Camber Capital Management
Massachusetts
-$20.1M
5
GTP
Global Thematic Partners
New York
-$18.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
76
Axa
France
$6.17M -$128K -1,378 -2%
AAM
77
Advisors Asset Management
Colorado
$6.1M +$21K +226 +0.3%
ZBI
78
Ziff Brothers Investments
New York
$5.87M +$3.46M +37,298 +149%
RPAM
79
Rhenman & Partners Asset Management
Sweden
$5.84M -$1.3M -14,000 -18%
CC
80
Casdin Capital
New York
$5.65M +$5.56M +60,000 New
Canada Pension Plan Investment Board
81
Canada Pension Plan Investment Board
Ontario, Canada
$5.37M -$4.3M -46,373 -45%
CS
82
Candriam SCA
Luxembourg
$5.37M -$501K -5,400 -9%
NFA
83
Nationwide Fund Advisors
Ohio
$5.32M +$811K +8,742 +18%
BlackRock
84
BlackRock
New York
$5.06M +$1.95M +21,003 +64%
DekaBank Deutsche Girozentrale
85
DekaBank Deutsche Girozentrale
Germany
$4.92M +$51K +550 +1%
PA
86
Profund Advisors
Maryland
$4.87M -$9.73K -105 -0.2%
JPMIA
87
J.P. Marvel Investment Advisors
Massachusetts
$4.83M +$4.76M +51,290 New
Allianz Asset Management
88
Allianz Asset Management
Germany
$4.81M – – –
GP
89
GLG Partners
United Kingdom
$4.74M -$643K -6,939 -12%
OPPM
90
Opus Point Partners Management
New York
$4.73M +$164K +1,774 +4%
AC
91
Ascend Capital
California
$4.71M +$4.64M +50,000 New
AllianceBernstein
92
AllianceBernstein
Tennessee
$4.7M -$110K -1,185 -2%
BCIM
93
British Columbia Investment Management
British Columbia, Canada
$4.52M +$2.41M +26,023 +118%
GTC
94
Ghost Tree Capital
New York
$4.24M +$4.17M +45,000 New
Ohio Public Employees Retirement System (OPERS)
95
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.03M +$570K +6,145 +17%
CCI
96
Columbus Circle Investors
$3.95M -$3.78M -40,782 -49%
BIM
97
BlackRock Investment Management
Delaware
$3.83M -$44.6K -481 -1%
SFM
98
Sphera Funds Management
Israel
$3.77M – – –
PPA
99
Parametric Portfolio Associates
Washington
$3.73M +$869K +9,373 +31%
JP Morgan Chase
100
JP Morgan Chase
New York
$3.55M -$10.8M -116,201 -75%
2 3
4
5 6

ALNY Hedge Fund Activity: Q4 2015 in Review

260 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q4 2015, worth a combined $6.22B — up 18% from $5.26B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ALNY positions and 39 closed out — a net gain of 5 holders — while 98 added to existing stakes and 75 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $187M. The largest seller was Amundi Asset Management US, exiting entirely with an estimated $50.8M sold.

  • 260 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q4 2015, up from 257 in Q3 2015.
  • Funds reported $6.22B of Alnylam Pharmaceuticals stock for Q4 2015, up 18% quarter-over-quarter.
  • 44 funds opened new Alnylam Pharmaceuticals positions in Q4 2015 and 39 closed out, a net change of +5 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q4 2015 was Baillie Gifford & Co, an estimated $187M added.
  • The largest Alnylam Pharmaceuticals seller in Q4 2015 was Amundi Asset Management US, an estimated $50.8M sold.

Based on aggregated 13F filings for Q4 2015.